Note Receivable - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Pharma
Note Receivable Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Note Receivable
â‚©2.7B
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Note Receivable
â‚©84.8m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Note Receivable
â‚©19.5B
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Note Receivable
â‚©6.6B
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Note Receivable
â‚©130.7m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
-27%

See Also

What is Daewoong Pharma's Note Receivable?
Note Receivable
2.7B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Note Receivable amounts to 2.7B KRW.

What is Daewoong Pharma's Note Receivable growth rate?
Note Receivable CAGR 5Y
13%

Over the last year, the Note Receivable growth was -20%. The average annual Note Receivable growth rates for Daewoong Pharma have been 21% over the past three years , 13% over the past five years .

Back to Top